Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab
Cindy X. Cai(Johns Hopkins University), Patrick Ryan(Johnson & Johnson (United States)), Evan Minty(University of Calgary), Michael E. Matheny(Vanderbilt University), Anthony G. Sena(Erasmus MC), Clair Blacketer(Erasmus MC), Anna Ostropolets(Columbia University), Paul Nagy(Johns Hopkins University), Kenar D. Jhaveri(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Diep Tran(Johns Hopkins University), Thomas Falconer(Columbia University), Jia Hwei Ng(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Priya Desai(Stanford Health Care), Jenna Reps(Janssen (United States)), Michael V. Boland(Massachusetts Eye and Ear Infirmary), Mary G. Bowring(Johns Hopkins University), Scott L. DuVall(University of Utah), Kerry Goetz(National Institutes of Health), Zachary Gilbert(Southern California Eye Institute), Marc A. Suchard(University of California, Los Angeles), Asieh Golozar(Northeastern University), Michelle R. Hribar(National Institutes of Health), Nathan Hall(Janssen (United States)), Deidra C. Crews(Johns Hopkins University), George Hripcsak(Columbia University Irving Medical Center), Azza Shoaibi(Office for National Statistics), Akihiko Nishimura(Johns Hopkins University), Brian C. Toy(Aravind Eye Hospital), Joel N. Swerdel(Janssen (United States)), Jody‐Ann McLeggon(Columbia University Irving Medical Center), Linying Zhang(Columbia University), Laurence Lawrence‐Archer(Northeastern University), Erik Westlund(Johns Hopkins University), Edward Lee(UCLA Medical Center), Scott L. Zeger(Johns Hopkins University), Fan Bu(University of Michigan), Michael B. Cook(National Cancer Institute)
Cited by 16
Related Papers
Bayesian Phylogeography Finds Its Roots
|PLoS Computational Biology|2009|1.9k
COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives
|Trends in Molecular Medicine|2020|723
Sex Disparities in Cancer Incidence by Period and Age
|Cancer Epidemiology Biomarkers & Prevention|2009|461